Nirland Ltd - 13 Jan 2025 SCHEDULE 13G Report for Conduit Pharmaceuticals Inc. Common Stock, $0.0001 par value (CDT)

Filing Manager
Nirland Ltd
Reporting Manager
Nirland Limited
Security
Conduit Pharmaceuticals Inc. Common Stock, $0.0001 par value
Symbol
CDT
Shares outstanding
153,823,028 shares
Disclosed Ownership
15,350,000 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
21 Jan 2025, 17:00:04 UTC
Date of event
13 Jan 2025
Next filing
20 Feb 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nirland Limited 10% 15,350,000 0 15,350,000 /s/ David Rowland David Rowland/Director
Stockton Limited 10% 15,350,000 0 15,350,000 /s/ David Rowland David Rowland/Director
The Rowland Master Trust 10% 15,350,000 0 15,350,000 /s/ Harley Rowland Harley Rowland/Director
Dovet Limited 10% 15,350,000 0 15,350,000 /s/ Harley Rowland Harley Rowland/Director